R2 Technology's proprietary mammography CAD has been approved by the FDA for sale with Fischer Imaging's SenoScan TrueView digital mammography system. Fischer plans to integrate R2's ImageChecker technology with SenoScan to support CAD analysis of
R2 Technology's proprietary mammography CAD has been approved by the FDA for sale with Fischer Imaging's SenoScan TrueView digital mammography system. Fischer plans to integrate R2's ImageChecker technology with SenoScan to support CAD analysis of digital mammograms.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.